THC Biomed Intl Ltd.
THC Biomed Intl Ltd. THCBF Peers
See (THCBF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| THCBF | $0.02 | +2350.00% | 58B | -2.45 | -$0.01 | N/A |
| CHALF | $0.38 | +3799900.00% | 441.8B | -4.75 | -$0.08 | N/A |
| STMH | $0.10 | +99900.00% | 125B | -0.05 | -$1.89 | N/A |
| MKGAF | $134.75 | +3.81% | 58.6B | 18.36 | $7.34 | +1.64% |
| MKKGY | $26.40 | +0.57% | 57.2B | 17.96 | $1.47 | +2.16% |
| TKPHF | $32.13 | N/A | 50.6B | 69.85 | $0.46 | +4.14% |
| HLNCF | $5.50 | -2.14% | 49.6B | 26.19 | $0.21 | +1.97% |
| KHRNF | $0.01 | +79900.00% | 41.6B | -0.80 | -$0.01 | N/A |
| IPSEY | $29.60 | +2.28% | 39.2B | 24.26 | $1.22 | +1.07% |
| EVRRF | $0.07 | +2780.00% | 25.5B | -2.40 | -$0.03 | N/A |
Stock Comparison
THCBF vs CHALF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CHALF has a market cap of 441.8B. Regarding current trading prices, THCBF is priced at $0.02, while CHALF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CHALF's P/E ratio is -4.75. In terms of profitability, THCBF's ROE is +0.00%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to CHALF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs STMH Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, STMH has a market cap of 125B. Regarding current trading prices, THCBF is priced at $0.02, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas STMH's P/E ratio is -0.05. In terms of profitability, THCBF's ROE is +0.00%, compared to STMH's ROE of -2.75%. Regarding short-term risk, THCBF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs MKGAF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, MKGAF has a market cap of 58.6B. Regarding current trading prices, THCBF is priced at $0.02, while MKGAF trades at $134.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas MKGAF's P/E ratio is 18.36. In terms of profitability, THCBF's ROE is +0.00%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, THCBF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs MKKGY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, MKKGY has a market cap of 57.2B. Regarding current trading prices, THCBF is priced at $0.02, while MKKGY trades at $26.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas MKKGY's P/E ratio is 17.96. In terms of profitability, THCBF's ROE is +0.00%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, THCBF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs TKPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TKPHF has a market cap of 50.6B. Regarding current trading prices, THCBF is priced at $0.02, while TKPHF trades at $32.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TKPHF's P/E ratio is 69.85. In terms of profitability, THCBF's ROE is +0.00%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, THCBF and TKPHF have similar daily volatility (0.00).
THCBF vs HLNCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HLNCF has a market cap of 49.6B. Regarding current trading prices, THCBF is priced at $0.02, while HLNCF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HLNCF's P/E ratio is 26.19. In terms of profitability, THCBF's ROE is +0.00%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, THCBF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs KHRNF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, KHRNF has a market cap of 41.6B. Regarding current trading prices, THCBF is priced at $0.02, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, THCBF's ROE is +0.00%, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, THCBF is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs IPSEY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, IPSEY has a market cap of 39.2B. Regarding current trading prices, THCBF is priced at $0.02, while IPSEY trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas IPSEY's P/E ratio is 24.26. In terms of profitability, THCBF's ROE is +0.00%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, THCBF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs EVRRF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, EVRRF has a market cap of 25.5B. Regarding current trading prices, THCBF is priced at $0.02, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, THCBF's ROE is +0.00%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, THCBF is less volatile compared to EVRRF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SDZNY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SDZNY has a market cap of 21.8B. Regarding current trading prices, THCBF is priced at $0.02, while SDZNY trades at $50.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SDZNY's P/E ratio is -2535.00. In terms of profitability, THCBF's ROE is +0.00%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs TEVJF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TEVJF has a market cap of 20.4B. Regarding current trading prices, THCBF is priced at $0.02, while TEVJF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TEVJF's P/E ratio is -15.48. In terms of profitability, THCBF's ROE is +0.00%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, THCBF and TEVJF have similar daily volatility (0.00).
THCBF vs SRUTF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SRUTF has a market cap of 19.5B. Regarding current trading prices, THCBF is priced at $0.02, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, THCBF's ROE is +0.00%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, THCBF is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs ESALY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, THCBF is priced at $0.02, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ESALY's P/E ratio is 20.54. In terms of profitability, THCBF's ROE is +0.00%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, THCBF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SGIOY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SGIOY has a market cap of 14.1B. Regarding current trading prices, THCBF is priced at $0.02, while SGIOY trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SGIOY's P/E ratio is 11.83. In terms of profitability, THCBF's ROE is +0.00%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, THCBF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SGIOF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SGIOF has a market cap of 12.9B. Regarding current trading prices, THCBF is priced at $0.02, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SGIOF's P/E ratio is 10.86. In terms of profitability, THCBF's ROE is +0.00%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, THCBF and SGIOF have similar daily volatility (0.00).
THCBF vs IPSEF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, THCBF is priced at $0.02, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas IPSEF's P/E ratio is 26.23. In terms of profitability, THCBF's ROE is +0.00%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, THCBF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs RDDTF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, RDDTF has a market cap of 9.7B. Regarding current trading prices, THCBF is priced at $0.02, while RDDTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, THCBF's ROE is +0.00%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to RDDTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BIOVF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, THCBF is priced at $0.02, while BIOVF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BIOVF's P/E ratio is 22.50. In terms of profitability, THCBF's ROE is +0.00%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, THCBF and BIOVF have similar daily volatility (0.00).
THCBF vs SFOSF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SFOSF has a market cap of 8.7B. Regarding current trading prices, THCBF is priced at $0.02, while SFOSF trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SFOSF's P/E ratio is 13.40. In terms of profitability, THCBF's ROE is +0.00%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, THCBF and SFOSF have similar daily volatility (0.00).
THCBF vs NOBDF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, THCBF is priced at $0.02, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas NOBDF's P/E ratio is N/A. In terms of profitability, THCBF's ROE is +0.00%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, THCBF is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs ESAIY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, THCBF is priced at $0.02, while ESAIY trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ESAIY's P/E ratio is 25.36. In terms of profitability, THCBF's ROE is +0.00%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, THCBF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs ESALF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, THCBF is priced at $0.02, while ESALF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ESALF's P/E ratio is 24.12. In terms of profitability, THCBF's ROE is +0.00%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, THCBF and ESALF have similar daily volatility (0.00).
THCBF vs GZPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, GZPHF has a market cap of 6.3B. Regarding current trading prices, THCBF is priced at $0.02, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, THCBF's ROE is +0.00%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, THCBF and GZPHF have similar daily volatility (0.00).
THCBF vs HKMPY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, THCBF is priced at $0.02, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, THCBF's ROE is +0.00%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, THCBF and HKMPY have similar daily volatility (0.00).
THCBF vs HKMPF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, THCBF is priced at $0.02, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, THCBF's ROE is +0.00%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, THCBF and HKMPF have similar daily volatility (0.00).
THCBF vs HLUBF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HLUBF has a market cap of 5.2B. Regarding current trading prices, THCBF is priced at $0.02, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HLUBF's P/E ratio is 11.31. In terms of profitability, THCBF's ROE is +0.00%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, THCBF and HLUBF have similar daily volatility (0.00).
THCBF vs HLBBF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, THCBF is priced at $0.02, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HLBBF's P/E ratio is 12.71. In terms of profitability, THCBF's ROE is +0.00%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, THCBF and HLBBF have similar daily volatility (0.00).
THCBF vs LVZPF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LVZPF has a market cap of 4.2B. Regarding current trading prices, THCBF is priced at $0.02, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, THCBF's ROE is +0.00%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, THCBF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs APNHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, THCBF is priced at $0.02, while APNHF trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas APNHF's P/E ratio is 15.08. In terms of profitability, THCBF's ROE is +0.00%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, THCBF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs APNHY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, THCBF is priced at $0.02, while APNHY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas APNHY's P/E ratio is 12.21. In terms of profitability, THCBF's ROE is +0.00%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, THCBF is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs INVVY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, THCBF is priced at $0.02, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas INVVY's P/E ratio is -62.42. In terms of profitability, THCBF's ROE is +0.00%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, THCBF and INVVY have similar daily volatility (0.00).
THCBF vs IZQVF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, THCBF is priced at $0.02, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, THCBF's ROE is +0.00%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, THCBF and IZQVF have similar daily volatility (0.00).
THCBF vs HYPMY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, THCBF is priced at $0.02, while HYPMY trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HYPMY's P/E ratio is 19.78. In terms of profitability, THCBF's ROE is +0.00%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, THCBF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs WIBFF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, WIBFF has a market cap of 2.8B. Regarding current trading prices, THCBF is priced at $0.02, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, THCBF's ROE is +0.00%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs ULIHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, THCBF is priced at $0.02, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, THCBF's ROE is +0.00%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, THCBF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs HMDCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, THCBF is priced at $0.02, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, THCBF's ROE is +0.00%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, THCBF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SHEZF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SHEZF has a market cap of 2.5B. Regarding current trading prices, THCBF is priced at $0.02, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, THCBF's ROE is +0.00%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, THCBF and SHEZF have similar daily volatility (0.00).
THCBF vs HTSUF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, THCBF is priced at $0.02, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HTSUF's P/E ratio is 16.10. In terms of profitability, THCBF's ROE is +0.00%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, THCBF and HTSUF have similar daily volatility (0.00).
THCBF vs DNPUF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, DNPUF has a market cap of 2.3B. Regarding current trading prices, THCBF is priced at $0.02, while DNPUF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas DNPUF's P/E ratio is 13.81. In terms of profitability, THCBF's ROE is +0.00%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, THCBF and DNPUF have similar daily volatility (0.00).
THCBF vs CHSYF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, THCBF is priced at $0.02, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, THCBF's ROE is +0.00%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, THCBF and CHSYF have similar daily volatility (0.00).
THCBF vs TSMRF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, THCBF is priced at $0.02, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, THCBF's ROE is +0.00%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, THCBF and TSMRF have similar daily volatility (0.00).
THCBF vs DMPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, THCBF is priced at $0.02, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas DMPHF's P/E ratio is 18.15. In terms of profitability, THCBF's ROE is +0.00%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, THCBF and DMPHF have similar daily volatility (0.00).
THCBF vs LBTSF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, THCBF is priced at $0.02, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LBTSF's P/E ratio is 162.50. In terms of profitability, THCBF's ROE is +0.00%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, THCBF and LBTSF have similar daily volatility (0.00).
THCBF vs LJUIF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, THCBF is priced at $0.02, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, THCBF's ROE is +0.00%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, THCBF and LJUIF have similar daily volatility (0.00).
THCBF vs NPNKF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, THCBF is priced at $0.02, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas NPNKF's P/E ratio is 7.55. In terms of profitability, THCBF's ROE is +0.00%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, THCBF and NPNKF have similar daily volatility (0.00).
THCBF vs CHIZF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CHIZF has a market cap of 1.7B. Regarding current trading prices, THCBF is priced at $0.02, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, THCBF's ROE is +0.00%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, THCBF and CHIZF have similar daily volatility (0.00).
THCBF vs YIHCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, YIHCF has a market cap of 1.7B. Regarding current trading prices, THCBF is priced at $0.02, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, THCBF's ROE is +0.00%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, THCBF and YIHCF have similar daily volatility (0.00).
THCBF vs EVOTF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, THCBF is priced at $0.02, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, THCBF's ROE is +0.00%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, THCBF and EVOTF have similar daily volatility (0.00).
THCBF vs SMDPY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, THCBF is priced at $0.02, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SMDPY's P/E ratio is 10.00. In terms of profitability, THCBF's ROE is +0.00%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, THCBF and SMDPY have similar daily volatility (0.00).
THCBF vs MITPF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, THCBF is priced at $0.02, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas MITPF's P/E ratio is -10.81. In terms of profitability, THCBF's ROE is +0.00%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, THCBF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs NPPNY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, THCBF is priced at $0.02, while NPPNY trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas NPPNY's P/E ratio is 6.89. In terms of profitability, THCBF's ROE is +0.00%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, THCBF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs KARBF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, THCBF is priced at $0.02, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas KARBF's P/E ratio is 262.50. In terms of profitability, THCBF's ROE is +0.00%, compared to KARBF's ROE of N/A. Regarding short-term risk, THCBF and KARBF have similar daily volatility (0.00).
THCBF vs ARSUF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ARSUF has a market cap of 1.5B. Regarding current trading prices, THCBF is priced at $0.02, while ARSUF trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ARSUF's P/E ratio is 18.78. In terms of profitability, THCBF's ROE is +0.00%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, THCBF is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs GTBIF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, THCBF is priced at $0.02, while GTBIF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas GTBIF's P/E ratio is 25.00. In terms of profitability, THCBF's ROE is +0.00%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, THCBF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs KSPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, THCBF is priced at $0.02, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas KSPHF's P/E ratio is 14.28. In terms of profitability, THCBF's ROE is +0.00%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, THCBF and KSPHF have similar daily volatility (0.00).
THCBF vs CASBF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CASBF has a market cap of 1.2B. Regarding current trading prices, THCBF is priced at $0.02, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CASBF's P/E ratio is -17.81. In terms of profitability, THCBF's ROE is +0.00%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, THCBF and CASBF have similar daily volatility (0.00).
THCBF vs SWGHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, THCBF is priced at $0.02, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, THCBF's ROE is +0.00%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, THCBF and SWGHF have similar daily volatility (0.00).
THCBF vs GNMLF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, THCBF is priced at $0.02, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, THCBF's ROE is +0.00%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, THCBF and GNMLF have similar daily volatility (0.00).
THCBF vs SHPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, THCBF is priced at $0.02, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, THCBF's ROE is +0.00%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, THCBF and SHPHF have similar daily volatility (0.00).
THCBF vs KKPCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, THCBF is priced at $0.02, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas KKPCF's P/E ratio is 10.46. In terms of profitability, THCBF's ROE is +0.00%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, THCBF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BIOGY Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, THCBF is priced at $0.02, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, THCBF's ROE is +0.00%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, THCBF and BIOGY have similar daily volatility (0.00).
THCBF vs NRXCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, NRXCF has a market cap of 839.1M. Regarding current trading prices, THCBF is priced at $0.02, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, THCBF's ROE is +0.00%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, THCBF and NRXCF have similar daily volatility (0.00).
THCBF vs TWAPF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, THCBF is priced at $0.02, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TWAPF's P/E ratio is 6.30. In terms of profitability, THCBF's ROE is +0.00%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, THCBF and TWAPF have similar daily volatility (0.00).
THCBF vs CSWYF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, THCBF is priced at $0.02, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, THCBF's ROE is +0.00%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, THCBF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs TCNNF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TCNNF has a market cap of 777.7M. Regarding current trading prices, THCBF is priced at $0.02, while TCNNF trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TCNNF's P/E ratio is -5.09. In terms of profitability, THCBF's ROE is +0.00%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, THCBF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs AGYTF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, THCBF is priced at $0.02, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, THCBF's ROE is +0.00%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, THCBF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs TRXPF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, THCBF is priced at $0.02, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, THCBF's ROE is +0.00%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, THCBF and TRXPF have similar daily volatility (0.00).
THCBF vs ABSCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ABSCF has a market cap of 682.7M. Regarding current trading prices, THCBF is priced at $0.02, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, THCBF's ROE is +0.00%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, THCBF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SWDCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, THCBF is priced at $0.02, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, THCBF's ROE is +0.00%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, THCBF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs NIKA Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, NIKA has a market cap of 667.1M. Regarding current trading prices, THCBF is priced at $0.02, while NIKA trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas NIKA's P/E ratio is N/A. In terms of profitability, THCBF's ROE is +0.00%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, THCBF and NIKA have similar daily volatility (0.00).
THCBF vs LVTTF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LVTTF has a market cap of 658.1M. Regarding current trading prices, THCBF is priced at $0.02, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, THCBF's ROE is +0.00%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs CURLF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CURLF has a market cap of 628.6M. Regarding current trading prices, THCBF is priced at $0.02, while CURLF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CURLF's P/E ratio is -2.52. In terms of profitability, THCBF's ROE is +0.00%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, THCBF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BOIRF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, THCBF is priced at $0.02, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, THCBF's ROE is +0.00%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, THCBF and BOIRF have similar daily volatility (0.00).
THCBF vs TRSSF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, THCBF is priced at $0.02, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, THCBF's ROE is +0.00%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, THCBF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs ELTP Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, ELTP has a market cap of 573.7M. Regarding current trading prices, THCBF is priced at $0.02, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas ELTP's P/E ratio is -26.85. In terms of profitability, THCBF's ROE is +0.00%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, THCBF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs MNFSF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, THCBF is priced at $0.02, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, THCBF's ROE is +0.00%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, THCBF is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs SGFEF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, SGFEF has a market cap of 536.5M. Regarding current trading prices, THCBF is priced at $0.02, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas SGFEF's P/E ratio is 22.98. In terms of profitability, THCBF's ROE is +0.00%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, THCBF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs CCHWF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, THCBF is priced at $0.02, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, THCBF's ROE is +0.00%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, THCBF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs AIHLF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, THCBF is priced at $0.02, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, THCBF's ROE is +0.00%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, THCBF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs PEXXF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, THCBF is priced at $0.02, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, THCBF's ROE is +0.00%, compared to PEXXF's ROE of N/A. Regarding short-term risk, THCBF and PEXXF have similar daily volatility (0.00).
THCBF vs KHTRF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, KHTRF has a market cap of 423.4M. Regarding current trading prices, THCBF is priced at $0.02, while KHTRF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas KHTRF's P/E ratio is 60.71. In terms of profitability, THCBF's ROE is +0.00%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, THCBF and KHTRF have similar daily volatility (0.00).
THCBF vs LRDSF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LRDSF has a market cap of 375.6M. Regarding current trading prices, THCBF is priced at $0.02, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, THCBF's ROE is +0.00%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, THCBF and LRDSF have similar daily volatility (0.00).
THCBF vs CNGGF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CNGGF has a market cap of 348.7M. Regarding current trading prices, THCBF is priced at $0.02, while CNGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CNGGF's P/E ratio is -0.09. In terms of profitability, THCBF's ROE is +0.00%, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, THCBF and CNGGF have similar daily volatility (0.00).
THCBF vs GLASF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, GLASF has a market cap of 295.3M. Regarding current trading prices, THCBF is priced at $0.02, while GLASF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas GLASF's P/E ratio is -64.44. In terms of profitability, THCBF's ROE is +0.00%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BHCCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, THCBF is priced at $0.02, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, THCBF's ROE is +0.00%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, THCBF and BHCCF have similar daily volatility (0.00).
THCBF vs PKBFF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, PKBFF has a market cap of 288.4M. Regarding current trading prices, THCBF is priced at $0.02, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, THCBF's ROE is +0.00%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, THCBF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BHHKF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BHHKF has a market cap of 288.1M. Regarding current trading prices, THCBF is priced at $0.02, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, THCBF's ROE is +0.00%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, THCBF is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs PSIQ Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, THCBF is priced at $0.02, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas PSIQ's P/E ratio is N/A. In terms of profitability, THCBF's ROE is +0.00%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, THCBF is less volatile compared to PSIQ. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs VRNOF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, VRNOF has a market cap of 230.6M. Regarding current trading prices, THCBF is priced at $0.02, while VRNOF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas VRNOF's P/E ratio is -0.65. In terms of profitability, THCBF's ROE is +0.00%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, THCBF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs CPHRF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CPHRF has a market cap of 230.1M. Regarding current trading prices, THCBF is priced at $0.02, while CPHRF trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CPHRF's P/E ratio is 24.94. In terms of profitability, THCBF's ROE is +0.00%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, THCBF and CPHRF have similar daily volatility (0.00).
THCBF vs CRLBF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CRLBF has a market cap of 205.7M. Regarding current trading prices, THCBF is priced at $0.02, while CRLBF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CRLBF's P/E ratio is -2.77. In terms of profitability, THCBF's ROE is +0.00%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, THCBF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs PLNHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, THCBF is priced at $0.02, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, THCBF's ROE is +0.00%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, THCBF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs WLDFF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, THCBF is priced at $0.02, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas WLDFF's P/E ratio is N/A. In terms of profitability, THCBF's ROE is +0.00%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, THCBF is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs BKUH Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, BKUH has a market cap of 150.7M. Regarding current trading prices, THCBF is priced at $0.02, while BKUH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas BKUH's P/E ratio is -50.00. In terms of profitability, THCBF's ROE is +0.00%, compared to BKUH's ROE of +0.10%. Regarding short-term risk, THCBF and BKUH have similar daily volatility (0.00).
THCBF vs HUMDF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, THCBF is priced at $0.02, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, THCBF's ROE is +0.00%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, THCBF and HUMDF have similar daily volatility (0.00).
THCBF vs COPHF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, THCBF is priced at $0.02, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas COPHF's P/E ratio is -0.02. In terms of profitability, THCBF's ROE is +0.00%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, THCBF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs PHCUF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, PHCUF has a market cap of 119.4M. Regarding current trading prices, THCBF is priced at $0.02, while PHCUF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas PHCUF's P/E ratio is 448.00. In terms of profitability, THCBF's ROE is +0.00%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, THCBF is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCBF.
THCBF vs LPCUF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, THCBF is priced at $0.02, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, THCBF's ROE is +0.00%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, THCBF and LPCUF have similar daily volatility (0.00).
THCBF vs CNVCF Comparison
THCBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCBF stands at 58B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, THCBF is priced at $0.02, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCBF currently has a P/E ratio of -2.45, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, THCBF's ROE is +0.00%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, THCBF and CNVCF have similar daily volatility (0.00).